281 related articles for article (PubMed ID: 15543576)
1. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
Quinlivan M; Gershon AA; Steinberg SP; Breuer J
J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
[TBL] [Abstract][Full Text] [Related]
4. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
[TBL] [Abstract][Full Text] [Related]
5. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
Quinlivan ML; Gershon AA; Steinberg SP; Breuer J
J Infect Dis; 2004 Aug; 190(4):793-6. PubMed ID: 15272408
[TBL] [Abstract][Full Text] [Related]
6. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between vaccine and wild-type varicella-zoster virus genotypes by high-resolution melt analysis of single nucleotide polymorphisms.
Toi CS; Dwyer DE
J Clin Virol; 2008 Sep; 43(1):18-24. PubMed ID: 18479962
[TBL] [Abstract][Full Text] [Related]
8. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
Sauerbrei A; Wutzler P
J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
[TBL] [Abstract][Full Text] [Related]
9. Amplification and sequencing of varicella-zoster virus (VZV) gene 4: point mutation in a VZV strain causing chickenpox during pregnancy.
Chow VT; Lim KP
Acta Virol; 1997 Oct; 41(5):277-83. PubMed ID: 9607081
[TBL] [Abstract][Full Text] [Related]
10. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine.
Loparev VN; Rubtcova E; Seward JF; Levin MJ; Schmid DS
J Infect Dis; 2007 Feb; 195(4):502-10. PubMed ID: 17230409
[TBL] [Abstract][Full Text] [Related]
11. Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification.
Higashimoto Y; Ihira M; Ohta A; Inoue S; Usui C; Asano Y; Yoshikawa T
J Clin Microbiol; 2008 Aug; 46(8):2665-70. PubMed ID: 18550736
[TBL] [Abstract][Full Text] [Related]
12. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
Sauerbrei A; Rubtcova E; Wutzler P; Schmid DS; Loparev VN
J Clin Microbiol; 2004 Dec; 42(12):5604-8. PubMed ID: 15583288
[TBL] [Abstract][Full Text] [Related]
13. [Genetic analysis of clinical varicella-zoster virus isolates collected in China].
Gan L; Wang ML; Zhao J; Chen JX
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb; 31(2):189-93. PubMed ID: 21215082
[TBL] [Abstract][Full Text] [Related]
14. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
[TBL] [Abstract][Full Text] [Related]
15. Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.
Quinlivan ML; Jensen NJ; Radford KW; Schmid DS
J Clin Microbiol; 2012 May; 50(5):1533-8. PubMed ID: 22378912
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
[TBL] [Abstract][Full Text] [Related]
17. Genotyping of varicella-zoster virus (vzv) wild-type strains isolated in the Czech Republic.
Bostikova V; Salavec M; Smetana J; Chlibek R; Kosina P; Prasil P; Plisek S; Splino M; Bostik P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Dec; 155(4):379-84. PubMed ID: 22336652
[TBL] [Abstract][Full Text] [Related]
18. Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus.
Lässker U; Harder TC; Hufnagel M; Suttorp M
Infection; 2002 Oct; 30(5):320-2. PubMed ID: 12382096
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).
Goulleret N; Mauvisseau E; Essevaz-Roulet M; Quinlivan M; Breuer J
Vaccine; 2010 Aug; 28(36):5878-82. PubMed ID: 20600487
[TBL] [Abstract][Full Text] [Related]
20. Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus.
Storlie J; Maresova L; Jackson W; Grose C
J Infect Dis; 2008 Mar; 197 Suppl 2():S49-53. PubMed ID: 18419408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
